These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25229403)

  • 1. The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa.
    Headley J; Lemons A; Corneli A; Agot K; Ahmed K; Wang M; Odhiambo J; Skhosana J; Tharaldson J; Van Damme L; MacQueen K;
    PLoS One; 2014; 9(9):e106410. PubMed ID: 25229403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.
    Corneli AL; McKenna K; Headley J; Ahmed K; Odhiambo J; Skhosana J; Wang M; Agot K;
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19152. PubMed ID: 25224613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
    Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
    AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP.
    Corneli A; Field S; Namey E; Agot K; Ahmed K; Odhiambo J; Skhosana J; Guest G
    PLoS One; 2015; 10(6):e0129177. PubMed ID: 26056842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial.
    Corneli A; Perry B; McKenna K; Agot K; Ahmed K; Taylor J; Malamatsho F; Odhiambo J; Skhosana J; Van Damme L
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):452-61. PubMed ID: 26536315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
    Namey E; Agot K; Ahmed K; Odhiambo J; Skhosana J; Guest G; Corneli A
    Cult Health Sex; 2016 Sep; 18(9):1081-91. PubMed ID: 27093238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widow cleansing and inheritance among the Luo in Kenya: the need for additional women-centred HIV prevention options.
    Perry B; Oluoch L; Agot K; Taylor J; Onyango J; Ouma L; Otieno C; Wong C; Corneli A
    J Int AIDS Soc; 2014; 17(1):19010. PubMed ID: 24973041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study.
    Ngure K; Thuo N; Ogello V; Kiptinness C; Kamolloh K; Burns BFO; Mugo NR; Bukusi EA; Garrison L; Baeten JM; Haberer JE
    Front Reprod Health; 2021; 3():637869. PubMed ID: 36304002
    [No Abstract]   [Full Text] [Related]  

  • 9. Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda.
    van der Straten A; King R; Grinstead O; Serufilira A; Allen S
    AIDS; 1995 Aug; 9(8):935-44. PubMed ID: 7576330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.
    Birdthistle I; Schaffnit SB; Kwaro D; Shahmanesh M; Ziraba A; Kabiru CW; Phillips-Howard P; Chimbindi N; Ondeng'e K; Gourlay A; Cowan FM; Hargreaves JR; Hensen B; Chiyaka T; Glynn JR; Floyd S
    BMC Public Health; 2018 Jul; 18(1):912. PubMed ID: 30045711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
    Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
    BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural practices, gender inequality and inconsistent condom use increase vulnerability to HIV infection: narratives from married and cohabiting women in rural communities in Mpumalanga province, South Africa.
    Madiba S; Ngwenya N
    Glob Health Action; 2017; 10(sup2):1341597. PubMed ID: 28678650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance.
    Manguro GO; Musau AM; Were DK; Tengah S; Wakhutu B; Reed J; Plotkin M; Luchters S; Gichangi P; Temmerman M
    BMC Public Health; 2022 Feb; 22(1):304. PubMed ID: 35164707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
    Corneli AL; McKenna K; Perry B; Ahmed K; Agot K; Malamatsho F; Skhosana J; Odhiambo J; Van Damme L
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):578-84. PubMed ID: 25761233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.
    Corneli AL; Deese J; Wang M; Taylor D; Ahmed K; Agot K; Lombaard J; Manongi R; Kapiga S; Kashuba A; Van Damme L;
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):324-31. PubMed ID: 25157647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the nexus of risk: Biobehavioral outcomes from a cluster randomized trial of the Women's Health CoOp Plus in Pretoria, South Africa.
    Wechsberg WM; Bonner CP; Zule WA; van der Horst C; Ndirangu J; Browne FA; Kline TL; Howard BN; Rodman NF
    Drug Alcohol Depend; 2019 Feb; 195():16-26. PubMed ID: 30562676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study.
    Thirumurthy H; Masters SH; Mavedzenge SN; Maman S; Omanga E; Agot K
    Lancet HIV; 2016 Jun; 3(6):e266-74. PubMed ID: 27240789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.